| # | Authors(s) | Title | Magazine | Year / Volume |
|
1
| Drucker, Aaron M.; Rosen, Cheryl F. | Drug-Induced Photosensitivity: Culprit Drugs, Management and Prevention | Drug Safety | 2011 (oktober) |
|
2
| Tuccori, Marco; Lapi, Francesco; Testi, Arianna; e | Drug-Induced Taste and Smell Alterations | Drug safety | 2011 (oktober) |
|
3
| Klein E.A., Thompson I.M., Baker L.H. | Vitamin E and the Risk of Prostate Cancer: The Selenium and Vitamin E Cancer Prevention Trial (SELECT) | JAMA | 2011;306(14):1549-1556 |
|
4
| Jones, S.C.; Sorbello, A; Boucher, R.M. | Fluoroquinolone-Associated Myasthenia Gravis Exacerbation: Evaluation of Postmarketing Reports from the US FDA Adverse Event Reporting System and a Li | Drug Safety | 34(10):839-847, October 1, 2011 |
|
5
| Grzeskowiak, Luke E.; Gilbert, Andrew L.; Morrison | Investigating Outcomes Following the Use of Selective Serotonin Reuptake Inhibitors for Treating Depression in Pregnancy: A Focus on Methodological Is | Drug Safety. | 34(11):1027-1048, November 1, 2011 |
|
6
| Janice Hopkins Tanne | Vaccine halves malaria episodes in children in Africa | BMJ | 2011;343;d6832 |
|
7
| Connolly,Stuart J., Camm,A. John, Halp,Jonathan L | Dronedarone in Permanent Atrial Fibrillation | The New England Journal of Medicine | 2011 November 14 |
|
8
| Budnitz Daniel S.,Lovegrove Maribeth C.,Shebab N. | Emergency Hospitalizations for Adverse Drug Events in Older Americans | The New England Journal of Medicine | 2011;365:2002-2012 |
|
9
| Trenque, T.; Herlem, E.; Auriche, P.; Dramé, M. | Serotonin Reuptake Inhibitors and Hyperprolactinaemia: A Case/Non-Case Study in the French Pharmacovigilance Database | Drug Safety | 34(12):1161-1166, December 1, 2011 |
|
10
| Younus, M.; Kissner, M.; Reich, L.; Wallis, N. | Putting the Cardiovascular Safety of Aromatase Inhibitors in Patients with Early Breast Cancer into Perspective: A Systematic Review of the Literature | Drug Safety | 34(12):1125-1149, December 1, 2011 |
|
11
| Varas-Lorenzo, C., Riera-Guardia, N., Calingaert, | Stroke risk and NSAIDs: a systematic review of observational studies | Pharmacoepidemiology & Drug Safety | 2011(20) |
|
12
| González,R.F., Calderón L.A., Poblador P.B., et al | Underreporting of recognized adverse drug reactions by primary care physicians: an exploratory study | Pharmacoepidemiology & Drug Safety | 2011(20) |
|
13
| Heart Protection Study Collaborative Group | Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20 536 high-risk individuals | The Lancet | Volume 378, Issue 9808 p1975-2048 |
|
14
| Habel Laurel A.,PhD; Cooper William O.,MD, MPH; | ADHD Medications and Risk of Serious Cardiovascular Events in Young and Middle-aged Adults | JAMA | 2011 online 12 december |
|
15
| v. Hunsel,F.;Härmark L;Pal S;Olsson S.;v.Groothees | Experiences with Adverse Drug Reaction Reporting by Patients: An 11-Country Survey | Drug Safety | Drug Safety. 35(1):45-60 |
|
16
| Makris, Marinos C.; Polyzos, Konstantinos A.; Mavr | Safety of Hepatitis B, Pneumococcal Polysaccharide and Meningococcal Polysaccharide Vaccines in Pregnancy: A Systematic Review | Drug Safety. | 35(1):1-14, January 1, 2012. |
|
17
| Harrison-Woolrych, Mira; Maggo, Simran; Tan, Ming; | Cardiovascular Events in Patients taking Varenicline: A Case Series from Intensive Postmarketing Surveillance in New Zealand | Drug Safety. | 35(1):33-43, |
|
18
| Matthew R Smith, Fred Saad, Robert Coleman | Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled tri | The Lancet | Volume 379, Issue 9810 p39-46 |
|
19
| Harry R Büller, Alex S Gallus, Gerard Pillion | Enoxaparin followed by once-weekly idrabiotaparinux versus enoxaparin plus warfarin for patients with acute symptomatic pulmonary embolism | The Lancet | 2012 Vol 379 |
|
20
| Fang Gao Smith, Gavin D Perkins, Simon Gates, | Effect of intravenous β-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2) | The Lancet | Volume 379, Issue 9812 p229-235 |
|
21
| Rolf Teschke, Jerome Sarris, Isaac Schweitzer | Kava hepatotoxicity in traditional and modern use: the presumed Pacific kava paradox hypothesis revisited | British Journal of Clinical Pharmacology | 2012; 73(2): 170–174 |
|
22
| Bond, G. Randall; Ho, Mona; Woodward, Randall W. | Trends in Hepatic Injury Associated with Unintentional Overdose of Paracetamol (Acetaminophen) in Products with and without Opioid | Drug Safety | 35(2):149-157, February 1, 2012 |
|
23
| Trifirò, G.; Mokhles, M.; Dieleman, J.P. | Risk of Cardiac Valve Regurgitation with Dopamine Agonist use in Parkinson's Disease and Hyperprolactinaemia | Drug Safety | 35(2):159-171, February 1, 2012 |
|
24
| Christopher JL Murray, Lisa C Rosenfeld, Stephen S | Global malaria mortality between 1980 and 2010: a systematic analysis | The Lancet | Volume 379, Issue 9814 p413-431 |
|
25
| Bond, G. Randall; Ho, Mona; Woodward, Randall W. | Nocebo Effects, Patient-Clinician Communication, and Therapeutic Outcomes | JAMA | 2012;307(6):567-568. doi: 10.1001/jama.2012. |
|
26
| Hyon K Choi, Lucia Cea Soriano, Yuqing Zhang | Antihypertensive drugs and risk of incident gout among patients with hypertension: population based case-control study | BMJ | 2012;344:d8190 |
|
27
| Helle Kieler, Miia Artama, Anders Engeland | Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study f | BMJ | 2011;344:d8012 |
|
28
| José Baselga, Ian Bradbury, Holger Eidtmann | Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial | The Lancet | Volume 379, Issue 9816 p633-640 |
|
29
| M.J. Boyce, K.J. Baisley, S.J. Warr | Pharmacokinetic interaction between domperidone and ketoconazole leads to QT prolongation in healthy volunteers: a randomized, placebo-controlled, dou | British Journal of Clinical Pharmacology | 2012; 73(3): 411–421 |
|
30
| Daniel B. Hawcutt, Pramod Mainie, Andrew Riordan e | Reported paediatric adverse drug reactions in the UK 2000–2009 | British Journal of Clinical Pharmacology | 2012; 73(3): 437–446 |
|
31
| Rebecca F McKnight, Marc Adida, Katie Budge | Lithium toxicity profile: a systematic review and meta-analysis | The Lancet | Volume 379, Issue 9817 p721-728 |
|
32
| Kripke DF, Langer RD, Kline LE. | Hypnotics’ association with mortality or cancer: a matched cohort study | BMJ | Open 2012;2: e000850. doi:10.1136/ bmjopen-201 |
|
33
| K F Huybrechts, T Gerhard, S Crystal | Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: population based cohort study | BMJ | 2012;344:e977 doi: 10.1136/bmj.e977 (Published 23 |
|
34
| Oosterhuis I, v. Hunsel F.P.A.M. v. Puijenbroek E. | Expectations for Feedback in Adverse Drug Reporting by Healthcare Professionals in the Netherlands | Drug Safety | 35(3):221-232, March 1, 2012 |
|
35
| Warlé-van Herwaarden, M.F.; Kramers, C.; Sturkenbo | Targeting Outpatient Drug Safety: Recommendations of the Dutch HARM-Wrestling Task Force | Drug Safety. | 35(3):245-259, March 1, 2012 |
|
36
| Neil E Fleshner, M Scott Lucia, Blair Egerdie, and | Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial | The Lancet | 2012 Volume 379, Issue 9821 p1103-1111 |
|
37
| Tamargo, Juan; Capucci, Alessandro; Mabo, Philippe | Safety of Flecainide | Drug Safety | 35(4):273-289, April 1, 2012 |
|
38
| Motola, Domenico; Piccinni, Carlo; Biagi, Chiara; | Cardiovascular, Ocular and Bone Adverse Reactions Associated with Thiazolidinediones: A Disproportionality Analysis of the US FDA Adverse Event Report | Drug Safety. | 35(4):315-323, April 1, 2012 |
|
39
| Mahyar Etminan, PharmD, MSc (epi); Farzin Forooghi | Oral Fluoroquinolones and the Risk of Retinal Detachment | JAMA | 2012 Vol 307 4 april |
|
40
| Maria Hoeltzenbein, Elisabeth Elefant, Thierry Via | Teratogenicity of Mycophenolate confirmed in a prospective study of the European Network of Teratology Information Services | American Journal of Medical Genetics part A | 2012 158A(3) Maart 2012 |
|
41
| Chor Kwan Ching, Ying Hoo Lam, Albert Y | Adulteration of herbal antidiabetic products with undeclared pharmaceuticals: a case series in Hong Kong | British Journal of Clinical Pharmacology | 2012 Vol 73 May |
|
42
| Peter M Rothwell, Michelle Wilson, Jacqueline F Pr | Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials | The Lancet | 2012 Vol 379 28 April |
|
43
| Reis, Ben Y.; Olson, Karen L.; Tian, Lu; Bohn, Rho | A Pharmacoepidemiological Network Model for Drug Safety Surveillance: Statins and Rhabdomyolysis | Drug Safety | 35(5):395-406, May 1, 2012 |